View ValuationMHP Hotel 将来の成長Future 基準チェック /16MHP Hotelの収益は年間5.9%で減少すると予測されていますが、年間収益は年間8.3%で増加すると予測されています。EPS は年間 減少すると予測されています。自己資本利益率は 3 年後に7.1% 5.6%なると予測されています。主要情報-5.9%収益成長率-5.58%EPS成長率Hospitality 収益成長72.0%収益成長率8.3%将来の株主資本利益率7.05%アナリストカバレッジLow最終更新日11 Jun 2026今後の成長に関する最新情報Breakeven Date Change • Jun 10Forecast breakeven date pushed back to 2025The 3 analysts covering MHP Hotel previously expected the company to break even in 2024. New consensus forecast suggests the company will make a profit of €6.10m in 2025. Average annual earnings growth of 72% is required to achieve expected profit on schedule.Breakeven Date Change • May 08Forecast breakeven date pushed back to 2025The 3 analysts covering MHP Hotel previously expected the company to break even in 2024. New consensus forecast suggests the company will make a profit of €6.10m in 2025. Average annual earnings growth of 74% is required to achieve expected profit on schedule.Price Target Changed • Apr 23Price target increased by 8.9% to €3.27Up from €3.00, the current price target is an average from 3 analysts. New target price is 142% above last closing price of €1.35. Stock is up 19% over the past year. The company is forecast to post earnings per share of €0.01 next year compared to a net loss per share of €0.15 last year.Price Target Changed • Mar 25Price target increased by 13% to €3.40Up from €3.00, the current price target is an average from 2 analysts. New target price is 162% above last closing price of €1.30. Stock is up 6.6% over the past year. The company is forecast to post earnings per share of €0.01 next year compared to a net loss per share of €0.15 last year.Price Target Changed • Feb 13Price target increased by 13% to €3.40Up from €3.00, the current price target is an average from 2 analysts. New target price is 143% above last closing price of €1.40. Stock is up 14% over the past year. The company is forecast to post earnings per share of €0.01 next year compared to a net loss per share of €0.15 last year.Price Target Changed • Oct 27Price target decreased by 13% to €3.10Down from €3.55, the current price target is an average from 3 analysts. New target price is 163% above last closing price of €1.18. Stock is down 7.8% over the past year.すべての更新を表示Recent updatesNew Risk • May 14New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 5.9% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings are forecast to decline by an average of 5.9% per year for the foreseeable future. High level of non-cash earnings (22% accrual ratio). Minor Risk Market cap is less than US$100m (€63.0m market cap, or US$73.8m).お知らせ • May 11MHP Hotel AG, Annual General Meeting, Jun 19, 2026MHP Hotel AG, Annual General Meeting, Jun 19, 2026, at 11:00 W. Europe Standard Time.New Risk • Jun 19New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 177% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Shares are highly illiquid. Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (€61.8m market cap, or US$70.9m).Reported Earnings • Jun 15Full year 2024 earnings releasedFull year 2024 results: Revenue: €174.7m (up 28% from FY 2023). Net income: €1.42m (up €7.90m from FY 2023). Profit margin: 0.8% (up from net loss in FY 2023). The move to profitability was driven by higher revenue. Revenue is forecast to grow 6.6% p.a. on average during the next 3 years, compared to a 9.3% growth forecast for the Hospitality industry in Germany.Breakeven Date Change • Jun 10Forecast breakeven date pushed back to 2025The 3 analysts covering MHP Hotel previously expected the company to break even in 2024. New consensus forecast suggests the company will make a profit of €6.10m in 2025. Average annual earnings growth of 72% is required to achieve expected profit on schedule.Breakeven Date Change • May 08Forecast breakeven date pushed back to 2025The 3 analysts covering MHP Hotel previously expected the company to break even in 2024. New consensus forecast suggests the company will make a profit of €6.10m in 2025. Average annual earnings growth of 74% is required to achieve expected profit on schedule.Price Target Changed • Apr 23Price target increased by 8.9% to €3.27Up from €3.00, the current price target is an average from 3 analysts. New target price is 142% above last closing price of €1.35. Stock is up 19% over the past year. The company is forecast to post earnings per share of €0.01 next year compared to a net loss per share of €0.15 last year.Price Target Changed • Mar 25Price target increased by 13% to €3.40Up from €3.00, the current price target is an average from 2 analysts. New target price is 162% above last closing price of €1.30. Stock is up 6.6% over the past year. The company is forecast to post earnings per share of €0.01 next year compared to a net loss per share of €0.15 last year.Price Target Changed • Feb 13Price target increased by 13% to €3.40Up from €3.00, the current price target is an average from 2 analysts. New target price is 143% above last closing price of €1.40. Stock is up 14% over the past year. The company is forecast to post earnings per share of €0.01 next year compared to a net loss per share of €0.15 last year.Price Target Changed • Oct 27Price target decreased by 13% to €3.10Down from €3.55, the current price target is an average from 3 analysts. New target price is 163% above last closing price of €1.18. Stock is down 7.8% over the past year.New Risk • Oct 19New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 39% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 39% per year for the foreseeable future. Minor Risks Share price has been volatile over the past 3 months (6.8% average weekly change). Shareholders have been diluted in the past year (9.3% increase in shares outstanding). Market cap is less than US$100m (€49.9m market cap, or US$52.8m).New Risk • Oct 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.3% average weekly change). Shareholders have been diluted in the past year (9.3% increase in shares outstanding). Market cap is less than US$100m (€51.2m market cap, or US$53.8m).Price Target Changed • Apr 27Price target increased to €3.54Up from €3.00, the current price target is provided by 1 analyst. New target price is 121% above last closing price of €1.60. Stock is up 16% over the past year.お知らせ • Jun 16Lifespot Capital AG (MUN:CDZ) entered into a contract to acquire Munich Hotel Partners Gmbh for €35.6 million.Lifespot Capital AG (MUN:CDZ) entered into a contract to acquire Munich Hotel Partners Gmbh for €35.6 million on June 15, 2021. In return for the shares brought in, the current Munich Hotel Partners Gmbh shareholders are to receive a cash component of €6 million and a share component of 33.1 million new shares in Lifespot Capital AG in accordance with the contribution agreement. The share component is to be granted by way of a capital increase in kind, on which the general meeting of Lifespot Capital AG still has to decide. Kai-Steffen Scholz and Markus Ernst of Hengeler Mueller Partnerschaft von Rechtsanwälten mbB are acting as legal advisors to the shareholders of Munich Hotel Partners Gmbh.Is New 90 Day High Low • Jan 21New 90-day high: €0.56The company is up 270% from its price of €0.15 on 23 October 2020. The German market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Healthcare Services industry, which is up 14% over the same period.Is New 90 Day High Low • Dec 04New 90-day high: €0.53The company is up 250% from its price of €0.15 on 04 September 2020. The German market is up 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Healthcare Services industry, which is up 14% over the same period.Is New 90 Day High Low • Nov 05New 90-day high: €0.25The company is up 67% from its price of €0.15 on 07 August 2020. The German market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Healthcare Services industry, which is up 5.0% over the same period.業績と収益の成長予測MUN:CDZ0 - アナリストの将来予測と過去の財務データ ( )EUR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20282625913312/31/20272494912312/31/20262263810212/31/20251786-63N/A12/31/20241611-26N/A9/30/2024152-3N/AN/AN/A6/30/2024144-7N/AN/AN/A3/31/2024140-7N/AN/AN/A12/31/2023136-601N/A12/31/2022105-7N/AN/AN/A12/31/201900N/AN/AN/A12/31/20180-1N/AN/AN/A12/31/20170-1N/AN/AN/A12/31/20160-2N/AN/AN/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: CDZ0の収益は今後 3 年間で減少すると予測されています (年間-5.9% )。収益対市場: CDZ0の収益は今後 3 年間で減少すると予測されています (年間-5.9% )。高成長収益: CDZ0の収益は今後 3 年間で減少すると予測されています。収益対市場: CDZ0の収益 ( 8.3% ) German市場 ( 6.7% ) よりも速いペースで成長すると予測されています。高い収益成長: CDZ0の収益 ( 8.3% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: CDZ0の 自己資本利益率 は、3年後には低くなると予測されています ( 7.1 %)。成長企業の発掘7D1Y7D1Y7D1YConsumer-services 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/12 21:52終値2026/06/10 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋MHP Hotel AG 3 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。4 アナリスト機関Oliver Wojahnmwb research AGChristian SandherrNuWays AGPhilipp SennewaldNuWays AG1 その他のアナリストを表示
Breakeven Date Change • Jun 10Forecast breakeven date pushed back to 2025The 3 analysts covering MHP Hotel previously expected the company to break even in 2024. New consensus forecast suggests the company will make a profit of €6.10m in 2025. Average annual earnings growth of 72% is required to achieve expected profit on schedule.
Breakeven Date Change • May 08Forecast breakeven date pushed back to 2025The 3 analysts covering MHP Hotel previously expected the company to break even in 2024. New consensus forecast suggests the company will make a profit of €6.10m in 2025. Average annual earnings growth of 74% is required to achieve expected profit on schedule.
Price Target Changed • Apr 23Price target increased by 8.9% to €3.27Up from €3.00, the current price target is an average from 3 analysts. New target price is 142% above last closing price of €1.35. Stock is up 19% over the past year. The company is forecast to post earnings per share of €0.01 next year compared to a net loss per share of €0.15 last year.
Price Target Changed • Mar 25Price target increased by 13% to €3.40Up from €3.00, the current price target is an average from 2 analysts. New target price is 162% above last closing price of €1.30. Stock is up 6.6% over the past year. The company is forecast to post earnings per share of €0.01 next year compared to a net loss per share of €0.15 last year.
Price Target Changed • Feb 13Price target increased by 13% to €3.40Up from €3.00, the current price target is an average from 2 analysts. New target price is 143% above last closing price of €1.40. Stock is up 14% over the past year. The company is forecast to post earnings per share of €0.01 next year compared to a net loss per share of €0.15 last year.
Price Target Changed • Oct 27Price target decreased by 13% to €3.10Down from €3.55, the current price target is an average from 3 analysts. New target price is 163% above last closing price of €1.18. Stock is down 7.8% over the past year.
New Risk • May 14New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 5.9% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings are forecast to decline by an average of 5.9% per year for the foreseeable future. High level of non-cash earnings (22% accrual ratio). Minor Risk Market cap is less than US$100m (€63.0m market cap, or US$73.8m).
お知らせ • May 11MHP Hotel AG, Annual General Meeting, Jun 19, 2026MHP Hotel AG, Annual General Meeting, Jun 19, 2026, at 11:00 W. Europe Standard Time.
New Risk • Jun 19New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 177% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Shares are highly illiquid. Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (€61.8m market cap, or US$70.9m).
Reported Earnings • Jun 15Full year 2024 earnings releasedFull year 2024 results: Revenue: €174.7m (up 28% from FY 2023). Net income: €1.42m (up €7.90m from FY 2023). Profit margin: 0.8% (up from net loss in FY 2023). The move to profitability was driven by higher revenue. Revenue is forecast to grow 6.6% p.a. on average during the next 3 years, compared to a 9.3% growth forecast for the Hospitality industry in Germany.
Breakeven Date Change • Jun 10Forecast breakeven date pushed back to 2025The 3 analysts covering MHP Hotel previously expected the company to break even in 2024. New consensus forecast suggests the company will make a profit of €6.10m in 2025. Average annual earnings growth of 72% is required to achieve expected profit on schedule.
Breakeven Date Change • May 08Forecast breakeven date pushed back to 2025The 3 analysts covering MHP Hotel previously expected the company to break even in 2024. New consensus forecast suggests the company will make a profit of €6.10m in 2025. Average annual earnings growth of 74% is required to achieve expected profit on schedule.
Price Target Changed • Apr 23Price target increased by 8.9% to €3.27Up from €3.00, the current price target is an average from 3 analysts. New target price is 142% above last closing price of €1.35. Stock is up 19% over the past year. The company is forecast to post earnings per share of €0.01 next year compared to a net loss per share of €0.15 last year.
Price Target Changed • Mar 25Price target increased by 13% to €3.40Up from €3.00, the current price target is an average from 2 analysts. New target price is 162% above last closing price of €1.30. Stock is up 6.6% over the past year. The company is forecast to post earnings per share of €0.01 next year compared to a net loss per share of €0.15 last year.
Price Target Changed • Feb 13Price target increased by 13% to €3.40Up from €3.00, the current price target is an average from 2 analysts. New target price is 143% above last closing price of €1.40. Stock is up 14% over the past year. The company is forecast to post earnings per share of €0.01 next year compared to a net loss per share of €0.15 last year.
Price Target Changed • Oct 27Price target decreased by 13% to €3.10Down from €3.55, the current price target is an average from 3 analysts. New target price is 163% above last closing price of €1.18. Stock is down 7.8% over the past year.
New Risk • Oct 19New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 39% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 39% per year for the foreseeable future. Minor Risks Share price has been volatile over the past 3 months (6.8% average weekly change). Shareholders have been diluted in the past year (9.3% increase in shares outstanding). Market cap is less than US$100m (€49.9m market cap, or US$52.8m).
New Risk • Oct 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.3% average weekly change). Shareholders have been diluted in the past year (9.3% increase in shares outstanding). Market cap is less than US$100m (€51.2m market cap, or US$53.8m).
Price Target Changed • Apr 27Price target increased to €3.54Up from €3.00, the current price target is provided by 1 analyst. New target price is 121% above last closing price of €1.60. Stock is up 16% over the past year.
お知らせ • Jun 16Lifespot Capital AG (MUN:CDZ) entered into a contract to acquire Munich Hotel Partners Gmbh for €35.6 million.Lifespot Capital AG (MUN:CDZ) entered into a contract to acquire Munich Hotel Partners Gmbh for €35.6 million on June 15, 2021. In return for the shares brought in, the current Munich Hotel Partners Gmbh shareholders are to receive a cash component of €6 million and a share component of 33.1 million new shares in Lifespot Capital AG in accordance with the contribution agreement. The share component is to be granted by way of a capital increase in kind, on which the general meeting of Lifespot Capital AG still has to decide. Kai-Steffen Scholz and Markus Ernst of Hengeler Mueller Partnerschaft von Rechtsanwälten mbB are acting as legal advisors to the shareholders of Munich Hotel Partners Gmbh.
Is New 90 Day High Low • Jan 21New 90-day high: €0.56The company is up 270% from its price of €0.15 on 23 October 2020. The German market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Healthcare Services industry, which is up 14% over the same period.
Is New 90 Day High Low • Dec 04New 90-day high: €0.53The company is up 250% from its price of €0.15 on 04 September 2020. The German market is up 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Healthcare Services industry, which is up 14% over the same period.
Is New 90 Day High Low • Nov 05New 90-day high: €0.25The company is up 67% from its price of €0.15 on 07 August 2020. The German market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Healthcare Services industry, which is up 5.0% over the same period.